Autism Spectrum Disorder Trial, Recruiting (NCT07590973)

Autism Spectrum Disorder Trial, Recruiting NCT07590973 Sponsor: Blinklab Limited Condition: Autism Spectrum Disorder

Printed from Voxsanity (voxsanity.com.au) — NCT07590973 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Autism Spectrum Disorder

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

The child must be between 2 and 11 years old
The child must have received the results of a neurodevelopmental assessment (based on standard diagnostic guidelines called DSM-5) within the past 12 months
Both the parent or caregiver and the child must be able to use English in the home environment
A parent or guardian must be able to read, understand, and voluntarily sign the consent form to participate
The child must be willing to be recorded on video during the assessment through the BlinkLab app

Who may not be able to join:

Families where the parent or caregiver does not have a smartphone that is compatible with the BlinkLab app
Children who have previously taken part in any clinical study run by BlinkLab
Families who are not able to complete all at-home study sessions from within the United States
Children who have a known history of seizures that are triggered by sounds, including any form of sound-induced or startle epilepsy

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 26 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 908-824-3471

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07590973

Sponsor: Blinklab Limited

Phase: Not Applicable

Status: Recruiting

Condition: Autism Spectrum Disorder

Trial contact: 908-824-3471

More information: https://clinicaltrials.gov/study/NCT07590973

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

The child must be between 2 and 11 years old
The child must have received the results of a neurodevelopmental assessment (based on standard diagnostic guidelines called DSM-5) within the past 12 months
Both the parent or caregiver and the child must be able to use English in the home environment
A parent or guardian must be able to read, understand, and voluntarily sign the consent form to participate
The child must be willing to be recorded on video during the assessment through the BlinkLab app

Who may not be able to join:

Families where the parent or caregiver does not have a smartphone that is compatible with the BlinkLab app
Children who have previously taken part in any clinical study run by BlinkLab
Families who are not able to complete all at-home study sessions from within the United States
Children who have a known history of seizures that are triggered by sounds, including any form of sound-induced or startle epilepsy

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 26 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Blinklab Limited

Registry

ClinicalTrials.gov

Start date

15 February 2025

Est. completion

1 September 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Sensitivity of BlinkLab Dx1; Specificity of BlinkLab Dx1

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov